Selective nonsteroidal anti-inflammatory drugs induce thymosin β-4 and alter actin cytoskeletal organization in human cancer cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 311, Issue 3, 2004, Pages 885-891

  Jain, Anshu K ^a   Moore, Scott M ^a   Yamaguchi, Kiyoshi ^b   Eling, Thomas E ^a   Baek, Seung Joon ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3 FLUOROPHENYL) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL) 2(5H) FURANONE; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ACETYLSALICYLIC ACID; ACTIN; DICLOFENAC; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN SYNTHASE; SULINDAC SULFIDE; THYMOSIN BETA4; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL GROWTH; CELL MOTILITY; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DNA LIBRARY; DRUG SELECTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; SUBTRACTIVE HYBRIDIZATION; TIME; WOUND HEALING;

ACTINS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, NORTHERN; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORECTAL NEOPLASMS; CYTOKINES; CYTOSKELETON; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INDICATORS AND REAGENTS; INDOMETHACIN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RNA, NEOPLASM; THYMOSIN;

EID: 10044270859     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.070664     Document Type: Article

References (40)

1. Baek SJ, Horowitz JM, and Eling TE (2001a) Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J Biol Chem 276:33384-33392.
2. Baek SJ, Kim JS, Nixon JB, DiAugustine RP, and Eling TE (2004) Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. J Biol Chem 279:6883-6892.
3. Baek SJ, Kim KS, Nixon JB, Wilson LC, and Eling TE (2001b) Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 59:901-908.
4. Baek SJ, Wilson LC, and Eling TE (2002a) Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-1) by increasing the expression of p53. Carcinogenesis 23:425-434.
5. Baek SJ, Wilson LC, Hsi LC, and Eling TE (2003) Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma: a novel mechanism for its anti-tumorigenic activity. J Biol Chem 278:5845-5853.
6. Baek SJ, Wilson LC, Lee CH, and Eling TE (2002b) Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): inhibition of cyclooxygenase and induction of NSAID-activated gene. J Pharmacol Exp Ther 301:1126-1131.
7. Bottone FG Jr, Baek SJ, Nixon JB, and Eling TE (2002) Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells. J Nutr 132:773-778.
8. Bottone FG Jr, Martinez JM, Alston-Mills B, and Eling TE (2004) Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells. Carcinogenesis 25:349-357.
9. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, and Prescott SM (2000) Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci USA 97:11280-11285.
10. Cassimeris L, Safer D, Nachmias VT, and Zigmond SH (1992) Thymosin beta 4 sequesters the majority of G-actin in resting human polymorphonuclear leukocytes. J Cell Biol 119:1261-1270.
11. Cha HJ, Jeong MJ, and Kleinman HK (2003) Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 95:1674-1680.
12. Chan TA, Morin PL, Vogelstein B, and Kinzler KW (1998) Mechanism underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 95:681-686.
13. Cheuk BLY, Chew SBC, Fiscus RR, and Wong PYD (2002) Cyclooxygenase-2 regulates apoptosis in rat epididymis through prostaglandin D2. Biol Reprod 66:374-380.
14. Clark EA, Golub TR, Lander ES, and Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature (Lond) 406:532-535.
15. Frohm M, Gunne H, Bergman AC, Agerberth B, Bergman T, Boman A, Liden S, Jornvall H, and Boman HG (1996) Biochemical and antibacterial analysis of human wound and blister fluid. Eur J Biochem 237:86-92.
16. Grant DS, Rose W, Yaen C, Goldstein A, Martinez J, and Kleinman H (1999) Thymosin beta4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 3:125-135.
17. Gwyn K and Sinicrope FA (2002) Chemoprevention of colorectal cancer. Am J Gastroenterol 97:13-21.
18. Hinz B and Brune K (2002) Cyclooxygenase-2: 10 years later. J Pharmacol Exp Ther 300:367-375.
19. Huff T, Muller CS, Otto AM, Netzker R, and Hannappel E (2001) beta-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 33:205-220.
20. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et al. (2003) MALAT-1, a novel noncoding RNA and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22:8031-8041.
21. Kobayashi T, Okada F, Fujii N, Tomita N, Ito S, Tazawa H, Aoyama T, Choi SK, Shibata T, Fujita H, et al. (2002) Thymosin-beta4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol 160:869-882.
22. Low TL, Hu SK, and Goldstein AL (1981) Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc Natl Acad Sci USA 78:1162-1166.
23. Malinda KM, Goldstein AL, and Kleinman HK (1997) Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J 11:474-481.
24. Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL, and Kleinman HK (1999) Thymosin beta4 accelerates wound healing. J Invest Dermatol 113:364-368.
25. Otto AM, Muller CS, Huff T, and Hannappel E (2002) Chemotherapeutic drugs change actin skeleton organization and the expression of beta-thymosins in human breast cancer cells. J Cancer Res Clin Oncol 128:247-256.
26. Philp D, Huff T, Gho YS, Hannappel E, and Kleinman HK (2003) The actin binding site on thymosin beta4 promotes angiogenesis. FASEB J 17:2103-2105.
27. Safer D, Elzinga M, and Nachmias VT (1991) Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem 266:4029-4032.
28. Safer D and Nachmias VT (1994) Beta thymosins as actin binding peptides. Bioessays 16:473-479.
29. Sanders MC, Goldstein AL, and Wang YL (1992) Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proc Natl Acad Sci USA 89:4678-4682.
30. Sosne G, Szliter EA, Barrett R, Kernacki KA, Kleinman H, and Hazlett LD (2002) Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res 74:293-299.
31. Taketo MM (1998) Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst 90:1529-1536.
32. Thun MJ (2003) NSAIDs and esophageal cancer: ready for trials but not yet broad clinical application. Gastroenterology 124:246-248.
33. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, and Heath CW Jr (1993) Aspirin use and risk of fatal cancer. Cancer Res 53:1322-1327.
34. Wang WS, Chen PM, Hsiao HL, Ju SY, and Su Y (2003) Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells. Oncogene 22:3297-3306.
35. Watson AJ (1998) Chemopreventive effects of NSAIDs against colorectal cancer: regulation of apoptosis and mitosis by COX-1 and COX-2. Histol Histopathol 13:591-597.
36. Wechter WJ, Kantoci D, Murray ED Jr, Quiggle DD, Leipold DD, Gibson KM, and McCracken JD (1997) R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer. Cancer Res 57:4316-4324.
37. Wechter WJ, Leipold DD, Murray ED Jr, Quiggle D, McCracken JD, Barrios RS, and Greenberg NM (2000) E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. Cancer Res 60:2203-2208.
38. Wilson LC, Baek SJ, Call A, and Eling TE (2003) Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int J Cancer 105:747-753.
39. Yamamoto T, Gotoh M, Kitajima M, and Hirohashi S (1993) Thymosin beta-4 expression is correlated with metastatic capacity of colorectal carcinomas. Biochem Biophys Res Commun 193:706-710.
40. Young JD, Lawrence AJ, MacLean AG, Leung BP, McInnes IB, Canas B, Pappin DJ, and Stevenson RD (1999) Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat Med 5:1424-1427.